Hong Kong's Causeway Bay may lose its crown as a slowdown in mainland tourists hits store sales, paving the way for its first drop in a decade.» Read More
May 21- Tiffany& Co reported a 13 percent rise in quarterly sales as the company's increasing focus on lower-priced jewelry attracted customers in the United States, its biggest market. Net profit rose to $125.6 million, or 97 cents per share, in the first quarter ended April 30 from $83.6 million, or 65 cents per share, a year earlier.
U.S. stock index futures signaled a higher open, despite ongoing concerns about weak earnings and global central bank policy.
Fed watchers could be spiced up with some new information on the Fed's post-bond buying strategy, which may lead to even more market volatility.
Stocks are likely to take their cue from the bond market, as traders worry low yields are a warning the economy isn't springing back.
Talking Squawk, the official "Squawk Box" blog, provides tidbits, insights, and some sarcastic reflections on the WEEK THAT WAS and the WEEK TO COME.
BEIJING/ SAN FRANCISCO, May 14- Alibaba is taking a tougher line against counterfeit items sold on its online marketplaces as the Chinese e-commerce giant heads towards a U.S. stock listing that could be the world's biggest technology company IPO.
Some of Thursday's midday movers:
The rich plan to spend more in 2014. On their wish list: Vacations, home improvement and cars. Fashion and collectibles are not as coveted.
BASEL, Switzerland, March 26- With their hundreds of years of watchmaking experience, Swiss watchmakers can afford to take a long view of technological fads and fashions.
U.S. stocks fell on Friday as investors considered Ukraine ahead of the weekend.
*Nike shares fall after results. Biogen Idec Inc, down 8.2 percent at $318.53, and Gilead Sciences Inc, down 4.6 percent at $72.07, were the two biggest drags on the S&P 500. The Nasdaq biotech index fell 4.4 percent.
*Nike shares fall after results, Tiffany rises. Biogen Idec Inc, down 8 percent to $319.14, and Gilead Sciences Inc, down 3.7 percent to $72.74, were the biggest drags on the S&P 500. The Nasdaq biotech index fell 3.5 percent.
Take a look at some of Friday's midday movers:
March 21- Tiffany& Co forecast more sales growth this year amid signs that the jeweler's business in its home U.S. market is finally perking up.
*Nike falls after results, Tiffany rises. Geopolitical issues remained in focus after President Vladimir Putin signed laws completing Russia's annexation of Crimea and investors took fright at a U.S. decision to slap sanctions on his inner circle.
A new report suggests that future growth for luxury will come from a new consumer. They're called YUMMY's—Young Urban Males.
Tiffany reported a loss in the fourth quarter, due primarily to losing an arbitration ruling involving The Swatch Group.
Breaking down Tiffany's quarterly earnings and the state of the luxury consumer, with Edward Yruma, KeyBanc Capital Markets Retail analyst.
CNBC's Jim Cramer shares his thoughts on Tiffany who reported weaker-than-expected earnings and the hot IPO market.
*Nike shares fall in premarket after outlook. NEW YORK, March 21- U.S. stock index futures pointed to a slightly higher open on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued.